BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 32276274)

  • 21. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
    Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
    BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease.
    Kim HA; Choi B; Suh CH; Han MH; Jung JY; Sayeed HM; Kim YW; Sohn S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still's disease and their association with cytokines.
    Yoshida S; Koga T; Fujita Y; Yatsuhashi H; Matsumoto H; Sumichika Y; Saito K; Sato S; Asano T; Kobayakawa M; Ohira H; Mizokami M; Sugiyama M; Migita K
    Front Immunol; 2024; 15():1385654. PubMed ID: 38711500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated levels of soluble Fas (APO-1, CD95), soluble Fas ligand, and matrix metalloproteinase-3 in sera from patients with active untreated adult onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    Clin Rheumatol; 2007 Mar; 26(3):393-400. PubMed ID: 16972019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still's disease.
    Fujita Y; Yago T; Asano T; Matsumoto H; Matsuoka N; Temmoku J; Sato S; Yashiro-Furuya M; Suzuki E; Watanabe H; Kawakami A; Migita K
    PLoS One; 2021; 16(8):e0255493. PubMed ID: 34351954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Interleukin-18 Provides a Clue to the Diagnosis of Adult-Onset Still's Disease: Findings from 6 Japanese Patients with Adult-Onset Still's Disease.
    Ogita A; Ansai SI; Saeki H
    J Nippon Med Sch; 2022 Mar; 89(1):114-118. PubMed ID: 34526450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease.
    Han JH; Ahn MH; Jung JY; Suh CH; Kwon JE; Yim H; Kim HA
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):67-73. PubMed ID: 31287410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
    Guo Q; Zha X; Li C; Jia Y; Zhu L; Guo J; Su Y
    Clin Rheumatol; 2016 Jan; 35(1):73-9. PubMed ID: 26547221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
    Chen X; Hu QY; Wang M; Jia J; Teng J; Sun Y; Cheng X; Ye J; Su Y; Shi H; Chi H; Zhou Z; Liu T; Wang Z; Wan L; Qiao X; Wang F; Wu X; Yang C; Liu HL
    Rheumatol Int; 2022 Jan; 42(1):149-157. PubMed ID: 34499196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome.
    Kasama T; Furuya H; Yanai R; Ohtsuka K; Takahashi R; Yajima N; Miwa Y; Kobayashi K
    Clin Rheumatol; 2012 May; 31(5):853-60. PubMed ID: 22322207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
    Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
    Front Immunol; 2020; 11():603389. PubMed ID: 33552062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease.
    Chen PK; Lan JL; Li JP; Chang CK; Chang SH; Huang PH; Yeo KJ; Chen DY
    Clin Rheumatol; 2020 Jun; 39(6):1945-1952. PubMed ID: 31960208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.
    Zhu D; Chen L; Meng J; Wang M; Ma Y; Chen X; Xiao Y; Yi D; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Zhou Z; Yang C; Teng J; Jia J; Hu Q
    J Autoimmun; 2024 Apr; 144():103182. PubMed ID: 38460457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage.
    Jia J; Yang L; Cao Z; Wang M; Ma Y; Ma X; Liu Q; Teng J; Shi H; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Liu T; Wang Z; Wan L; Yang C; Hu Q
    Rheumatology (Oxford); 2021 Jan; 60(1):304-315. PubMed ID: 32766690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
    Duan M; Shen M; Zhou Y; He Y; Guo Z; Ye C; Li J; Zhu L
    Clin Rheumatol; 2023 Jun; 42(6):1635-1643. PubMed ID: 36418508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
    Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
    Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 6: a possible marker of disease activity in adult onset Still's disease.
    Scheinberg MA; Chapira E; Fernandes ML; Hubscher O
    Clin Exp Rheumatol; 1996; 14(6):653-5. PubMed ID: 8978961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.
    Han JH; Suh CH; Jung JY; Nam JY; Kwon JE; Yim H; Kim HA
    Arthritis Res Ther; 2015 Sep; 17(1):260. PubMed ID: 26385705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of circulating microRNA-134 in adult-onset Still's disease and its use as potential biomarker.
    Liao TL; Chen YM; Hsieh CW; Chen HH; Lee HC; Hung WT; Tang KT; Chen DY
    Sci Rep; 2017 Jun; 7(1):4214. PubMed ID: 28646209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.